# Opioid receptors: single molecule studies shed light on mechanisms of efficacy

**Authors:** Cornelius Krasel, Moritz Bünemann

PMC · DOI: 10.1038/s41392-024-01920-2 · Signal Transduction and Targeted Therapy · 2024-08-30

## Full-text entities

- **Genes:** ARRB1 (arrestin beta 1) [NCBI Gene 408] {aka ARB1, ARR1}, ADRB2 (adrenoceptor beta 2) [NCBI Gene 154] {aka ADRB2R, ADRBR, ARB2, B2AR, BAR, BETA2AR}, OXER1 (oxoeicosanoid receptor 1) [NCBI Gene 165140] {aka GPCR, GPR170, TG1019}, GNAI1 (G protein subunit alpha i1) [NCBI Gene 2770] {aka Gi, HG1B, NEDHISB}
- **Diseases:** pain (MESH:D010146), respiratory depression (MESH:D012131), addiction (MESH:D019966)
- **Chemicals:** lofentanil (MESH:C034846), GDP (MESH:D006153), TRV130 (MESH:C586842), cysteine (MESH:D003545), morphine (MESH:D009020), MP (MESH:C063925), BU72 (-), naloxone (MESH:D009270), buprenorphine (MESH:D002047), Cy5 (MESH:C085321)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11362334/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11362334/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC11362334/full.md

---
Source: https://tomesphere.com/paper/PMC11362334